ROMIDEPSIN for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 16 adverse event reports in the FDA FAERS database where ROMIDEPSIN was used for Neoplasm malignant.

Most Reported Side Effects for ROMIDEPSIN

Side Effect	Reports	%	Deaths	Hosp.
Peripheral t-cell lymphoma unspecified	102	8.0%	73	18
Nausea	91	7.1%	11	33
Death	90	7.0%	90	10
Thrombocytopenia	90	7.0%	23	29
Pyrexia	77	6.0%	18	49
Drug ineffective	69	5.4%	19	25
Anaemia	61	4.8%	14	21
Electrocardiogram qt prolonged	61	4.8%	5	3
Platelet count decreased	60	4.7%	22	24
Vomiting	57	4.5%	5	28
Fatigue	55	4.3%	7	21
Product storage error	53	4.1%	0	0
Atrial fibrillation	52	4.1%	9	23
Neutropenia	49	3.8%	9	10
Malignant neoplasm progression	45	3.5%	17	8